Agenus
AGEN
#8939
Rank
A$0.20 B
Marketcap
A$6.14
Share price
-2.64%
Change (1 day)
15.09%
Change (1 year)

Agenus (AGEN) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.35 Billion

According to Agenus 's latest financial reports the company's total assets are A$0.35 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Agenus - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.36 B-21.05%
2023-12-31A$0.46 B-24.18%
2022-12-31A$0.60 B-5.45%
2021-12-31A$0.64 B130.38%
2020-12-31A$0.27 B25.74%
2019-12-31A$0.22 B14.59%
2018-12-31A$0.19 B9.22%
2017-12-31A$0.17 B-18.6%
2016-12-31A$0.21 B-34.5%
2015-12-31A$0.33 B265.14%
2014-12-31A$91.06 M133.17%
2013-12-31A$39.05 M39.5%
2012-12-31A$27.99 M44.92%
2011-12-31A$19.31 M-36.51%
2010-12-31A$30.42 M-40.42%
2009-12-31A$51.06 M-36.59%
2008-12-31A$80.53 M58.1%
2007-12-31A$50.94 M-44.95%
2006-12-31A$92.54 M-34.98%
2005-12-31A$0.14 B-17.22%
2004-12-31A$0.17 B-8.76%
2003-12-31A$0.18 B19.22%
2002-12-31A$0.15 B-13.76%
2001-12-31A$0.18 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
A$195.79 B 55,287.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.63 B 35,155.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$291.42 B 82,338.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.98 B 177.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$146.43 B 41,324.85%๐Ÿ‡บ๐Ÿ‡ธ USA